Table 1.

Patients demographic at baseline.

Included patients	N = 61
Mean age, years (SD)	38.4 ± 3 (5.7)
Female sex, n (%)	35 (57)
EDSS at study entry	1.5 ± 1
Disease-modifying treatment, n (%)	61 (100)
Mean follow-up time, years (SD)	3 ± 0.5
Years of education, SD	12 ± 3
Disease duration, months (SD)	10 ± 6
Cognitive impairment, n (%)	0